lamictal 100mg dispersible tablets
sigma pharmaceuticals plc - lamotrigine - dispersible tablet - 100mg
lamictal 5mg dispersible tablets
sigma pharmaceuticals plc - lamotrigine - dispersible tablet - 5mg
lamictal 100mg dispersible tablets
lexon (uk) ltd - lamotrigine - dispersible tablet - 100mg
lamictal 5mg dispersible tablets
mawdsley-brooks & company ltd - lamotrigine - dispersible tablet - 5mg
lamictal 5mg dispersible tablets
stephar (u.k.) ltd - lamotrigine - dispersible tablet - 5mg
lamictal 100mg dispersible tablets
de pharmaceuticals - lamotrigine - dispersible tablet - 100mg
lamictal lamotrigine 5 mg dispersible/chewable tablet blister pack
aspen pharmacare australia pty ltd - lamotrigine, quantity: 5 mg - tablet - excipient ingredients: magnesium stearate; aluminium magnesium silicate; calcium carbonate; saccharin sodium; povidone; sodium starch glycollate; hyprolose; flavour - lamictal is an anti-epileptic drug for the treatment of partial and generalised seizures in adults and children. there is extensive experience with lamictal used initially as add-on therapy. the use of lamictal has also been found to be effective as monotherapy following withdrawal of concomitant anti-epileptic drugs. initial monotherapy treatment in newly diagnosed paediatric patients is not recommended (see clinical trials). lamictal is indicated for the prevention of depressive episodes in patients with bipolar disorder.
lamictal lamotrigine 25 mg tablet blister pack
aspen pharmacare australia pty ltd - lamotrigine, quantity: 25 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; lactose monohydrate; povidone; iron oxide yellow; magnesium stearate - lamictal is an anti-epileptic drug for the treatment of partial and generalised seizures in adults and children. there is extensive experience with lamictal used initially as ?add-on? therapy. the use of lamictal has also been found to be effective as monotherapy following withdrawal of concomitant anti-epileptic drugs. initial monotherapy treatment in newly diagnosed paediatric patients is not recommended (see clinical trials). lamictal is indicated for the prevention of depressive episodes in patients with bipolar disorder.
lamictal 100mg dispersible tablets
mawdsley-brooks & company ltd - lamotrigine - dispersible tablet - 100mg
lamictal 5 mg chewable/disp. tabl.
glaxosmithkline pharmaceuticals sa-nv - lamotrigine 5 mg - chewable/dispersible tablet - 5 mg - lamotrigine 5 mg - lamotrigine